Free Trial
OTCMKTS:BIOVF

Swedish Orphan Biovitrum (BIOVF) Stock Price, News & Analysis

Swedish Orphan Biovitrum logo
$29.79 0.00 (0.00%)
As of 08/1/2025

About Swedish Orphan Biovitrum Stock (OTCMKTS:BIOVF)

Key Stats

Today's Range
$29.79
$29.79
50-Day Range
$27.06
$31.99
52-Week Range
$24.08
$32.25
Volume
N/A
Average Volume
65 shs
Market Capitalization
$10.61 billion
P/E Ratio
25.03
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive BIOVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Swedish Orphan Biovitrum and its competitors with MarketBeat's FREE daily newsletter.

BIOVF Stock News Headlines

A new rule goes live in July — and the banks are quietly crushing it
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

BIOVF Stock Analysis - Frequently Asked Questions

Swedish Orphan Biovitrum's stock was trading at $27.66 at the beginning of 2025. Since then, BIOVF stock has increased by 7.7% and is now trading at $29.79.

Swedish Orphan Biovitrum (OTCMKTS:BIOVF) announced its quarterly earnings results on Wednesday, July, 16th. The company reported $0.24 EPS for the quarter, topping analysts' consensus estimates of $0.18 by $0.06. The firm had revenue of $649.61 million for the quarter, compared to analyst estimates of $644.68 million. Swedish Orphan Biovitrum had a net margin of 16.05% and a trailing twelve-month return on equity of 11.67%.

Shares of BIOVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/16/2025
Today
8/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
N/A
Current Symbol
OTCMKTS:BIOVF
CIK
N/A
Fax
N/A
Employees
1,772
Year Founded
2001

Profitability

EPS (Trailing Twelve Months)
$1.19
Trailing P/E Ratio
25.03
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$367.52 million
Net Margins
16.05%
Pretax Margin
18.72%
Return on Equity
11.67%
Return on Assets
6.34%

Debt

Debt-to-Equity Ratio
0.22
Current Ratio
1.00
Quick Ratio
0.66

Sales & Book Value

Annual Sales
$2.46 billion
Price / Sales
4.31
Cash Flow
$2.05 per share
Price / Cash Flow
14.52
Book Value
$11.36 per share
Price / Book
2.62

Miscellaneous

Outstanding Shares
356,000,000
Free Float
N/A
Market Cap
$10.61 billion
Optionable
Not Optionable
Beta
0.46

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (OTCMKTS:BIOVF) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners